关注
Jayalaxmi Suresh Babu
Jayalaxmi Suresh Babu
Johns Hopkins University
在 jh.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Immune-related events in individuals with solid tumors on immunotherapy associate with Th17 and Th2 signatures
CJ Kao, S Charmsaz, SL Alden, M Brancati, HL Li, A Balaji, K Munjal, ...
The Journal of Clinical Investigation 134 (20), 2024
32024
Generation of the NeoThy mouse model for human immune system studies
NM Del Rio, L Huang, L Murphy, JS Babu, CM Daffada, WJ Haynes, ...
Lab animal 52 (7), 149-168, 2023
22023
Diminished Immune Cell Adhesion in Hypoimmune ICAM-1 Knockout Pluripotent Stem Cells
S Saha, WJ Haynes, N Del Rio, EE Young, J Zhang, J Seo, L Huang, ...
bioRxiv, 2024.06. 07.597791, 2024
12024
Abstract B003: Validating PTPN22 as a cancer-agnostic immunotherapeutic target
JS Babu, S Charmsaz, NE Gross, AG Hernandez, CD Cannon, X Yuan, ...
Cancer Immunology Research 12 (10_Supplement), B003-B003, 2024
2024
Phosphodiesterase-5 inhibition collaborates with vaccine-based immunotherapy to reprogram myeloid cells in pancreatic ductal adenocarcinoma
NE Gross, Z Zhang, JT Mitchell, S Charmsaz, AG Hernandez, EM Coyne, ...
JCI insight 9 (18), e179292, 2024
2024
系统目前无法执行此操作,请稍后再试。
文章 1–5